SANDERSON DESIGN GROUP PLC
SDG | IL
Overview
Corporate Details
- ISIN(s):
- GB0003061511
- LEI:
- 213800A8K2WOUZJIQL93
- Country:
- United Kingdom
- Address:
- VOYSEY HOUSE, W4 4DS LONDON
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Sareum Holdings PLC is a clinical-stage biotech developing next-generation kinase inhibitors for autoimmune diseases & cancer.Ê Our focus is on TYK2/JAK1 inhibitors, with lead candidate SDC-1801 in Phase 1a/b trials for psoriasis and SDC-1802 for cancer immunotherapy.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-03 14:24 |
Declaration of Voting Results & Voting Rights Announcements
Vesting of Awards under LTIP & Total Voting Rights
|
English | 34.0 KB | |
| 2025-06-02 08:00 |
Report Publication Announcement
Annual Report and Notice of AGM
|
English | 16.8 KB | |
| 2025-03-13 16:11 |
Major Shareholding Notification
Notification of Major Holdings
|
English | 22.2 KB | |
| 2025-02-17 12:59 |
Directors' Dealings
Notification of Director Share Ownership
|
English | 30.4 KB | |
| 2025-02-03 17:55 |
Board/Management Change
Non-Executive Board Change
|
English | 15.6 KB | |
| 2025-01-22 17:05 |
Major Shareholding Notification
Notification of Major Holdings
|
English | 22.4 KB | |
| 2025-01-20 18:18 |
Directors' Dealings
PDMR Share Purchase
|
English | 28.2 KB | |
| 2025-01-20 15:38 |
Directors' Dealings
Director Share Purchases
|
English | 31.5 KB | |
| 2025-01-20 08:00 |
Regulatory News Service
Trading Update
|
English | 19.8 KB | |
| 2024-12-19 08:00 |
Regulatory News Service
Sanderson awarded Royal Warrant
|
English | 16.8 KB | |
| 2024-12-02 12:45 |
Major Shareholding Notification
Notification of Major Holdings
|
English | 43.3 KB | |
| 2024-12-02 12:15 |
Regulatory News Service
Total Voting Rights
|
English | 15.2 KB | |
| 2024-11-25 08:00 |
Regulatory News Service
Non-Executive Board Change
|
English | 15.9 KB | |
| 2024-11-13 17:05 |
Directors' Dealings
Director/PDMR Shareholding and Total Voting Rights
|
English | 33.0 KB | |
| 2024-11-04 08:00 |
Regulatory News Service
Senior Appointments in the UK and North America
|
English | 18.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Herantis Pharma Oyj | Finland | HRTIS | |
| Hiron-Trade Investments & Industrial Buildings Ltd. | Israel | HRON | ||
|
Human Stem Cells Institute PJSC | Russian Federation | ISKJ | |
|
Human Xtensions Ltd. | Israel | HUMX | |
|
Hybrigenics SA | France | ALHYG | |
|
Hyloris Pharmaceuticals SA | Belgium | HYL | |
|
Ikonisys S.A. | France | ALIKO | |
|
IMCB PJSC | Russian Federation | GEMA | |
|
Inify Laboratories AB | Sweden | INIFY | |
|
Innate Pharma | France | IPH |